The Russian Sputnik V vaccine has not yet been authorized by the World Health Organization (WHO), as is the case with the doses of Pfizer, Moderna, Astrazeneca, Janssen, Sinopharm and Sinovac, since the homologation process is suspended. , as confirmed by Jarbas Barbosa, deputy director of the Pan American Health Organization (PAHO), WHO regional office.
“The authorization process for the emergency use of the Sputnik V vaccine by the WHO has been suspended since June,” said the official.
The reason for the delay in homologation is due to the fact that the WHO requested more information from the Gamaleya Institute, manufacturer of the Russian vaccine, after inspecting the laboratory facilities and finding “some deficiencies,” according to Dmitry Peskov, a Kremlin spokesman. , who also stated that “everything that had to be changed was taken into account and changed.”
Barbosa explained that “this suspension occurred because conditions were found in a plant that produced Sputnik vaccines that were not adequate for good production practices. Then, (the process) is suspended, waiting for the producer to adopt the necessary measures so that another inspection can go and certify that the conditions are adequate ”.
In any case, the authorization of the WHO is not essential for the application of the doses of Sputnik V, which is already used in more than 70 countries, including Argentina. Although it could be an impediment for travelers, since in some regions such as Europe, only those travelers who have the approved doses of vaccines can enter.